MedTrace Logo

Impact of Von Willebrand Factor and Its Multimers on Angiogenesis

NCT04810702 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2024-03-22

No results posted yet for this study

Summary

The study aims to study the expression of numerous proteins involved in angiogenesis in 70 patients with von Willebrand disease in order to try to identify markers of interest. Secondly, the investigators plan to investigate whether there is a relationship between the proteins tested, the distribution of multimers and the clinical phenotype of the patients, in particular by looking for the presence of bleeding linked to the presence of angiodysplasias.

Conditions

  • Von Willebrand Diseases

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-07
Primary Completion
2024-08-07
Completion
2024-08-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04810702 on ClinicalTrials.gov